Yield Seekers May Still Be Interested in BAT

Despite their recent run, shares in British American Tobacco might still be of interest to risk-averse and high-yield investors and those seeking shelter from inflation

Philip Gorham, CFA 29 July, 2011 | 10:59AM
Facebook Twitter LinkedIn

British American Tobacco's (BATS) first-half results revealed a fairly strong performance, supporting our comments over many months that investments in tobacco firms can provide a safe haven from the commodity cost inflation and weak pricing power afflicting many other consumer staples companies at present. The firm appears on track to meet our full-year forecasts, and we are reiterating our fair value estimate as well as our long-term outlook. After their decent run over the last quarter, we believe the shares are very modestly overvalued, although risk-averse and high-yield investors may still find the story interesting.

For the entire note and research report, click here.

Morningstar's Equity Analyst Notes and Equity Research Reports contain our independent view on a company's investment case, valuation, financial health and stewardship, and are available to Premium subscribers.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
British American Tobacco PLC2,880.00 GBX0.17Rating

About Author

Philip Gorham, CFA  Philip Gorham, CFA, is an associate director of equity research for Morningstar.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures